跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
Adult lymphoblastic lymphoma in Taiwan: An analysis of treatment results of 26 patients
Y. C. Chen, C. L. Ho, W. Y. Kao, J. M. Hwang, L. F. Sheu,
T. Y. Chao
研究成果
:
雜誌貢獻
›
文章
›
同行評審
11
引文 斯高帕斯（Scopus）
總覽
指紋
指紋
深入研究「Adult lymphoblastic lymphoma in Taiwan: An analysis of treatment results of 26 patients」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Lymphoblastic Lymphoma
100%
Oncology
66%
Disease
55%
Prednisone
55%
Cyclophosphamide
44%
Vincristine
44%
High Dose Chemotherapy
44%
Autologous Bone Marrow Transplantation
33%
Chemotherapy
22%
Overall Survival
22%
Disease Free Survival
22%
Allogenic Bone Marrow Transplantation
22%
Chlormethine
22%
Doxorubicin
22%
Etoposide
22%
Methotrexate
22%
Procarbazine
22%
Medical Record
11%
Hepatitis
11%
T Cell
11%
Progression Free Survival
11%
B Cell
11%
Mediastinum Mass
11%
B Symptoms
11%
Cell Lineage
11%
Peripheral Blood Stem Cell Transplantation
11%
Autologous Peripheral Blood Stem Cell Transplantation
11%
Immunology and Microbiology
Prednisone
100%
Drug Megadose
80%
Cyclophosphamide
80%
Bone Marrow Transplantation
60%
Overall Survival
40%
Disease Free Survival
40%
Methotrexate
40%
B Cell
20%
Medical Record
20%
Cell Lineage
20%
Allogeneic Bone Marrow Transplantation
20%
Autologous Peripheral Blood Stem Cell Transplantation
20%
Peripheral Blood Stem Cell Transplantation
20%
Progression Free Survival
20%
T Cell
20%
Pharmacology, Toxicology and Pharmaceutical Science
Lymphoblastoma
100%
Disease
55%
Prednisone
55%
Cyclophosphamide
44%
High Dose Chemotherapy
44%
Vincristine
44%
Doxorubicin
22%
Overall Survival
22%
Disease Free Survival
22%
Methotrexate
22%
Etoposide
22%
Nitrogen Mustard
22%
Procarbazine
22%
Symptom
11%
Chemotherapy
11%
Progression Free Survival
11%
Remission
11%
Mediastinum Mass
11%
Hepatitis
11%